Clinical Trials Browser

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Anal Canal Carcinoma, Anus Neoplasms

Ureteral Neoplasms

Oropharyngeal Neoplasms

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Renal Cell

Leukemia, Leukemia, Myeloid, Acute

Retinoblastoma

Carcinoma, Intraductal, Noninfiltrating

Neuroblastoma, Ganglioneuroblastoma

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

Smoldering Multiple Myeloma

Urinary Bladder Neoplasms

Prostatic Neoplasms

Pathologic Complete Response, Leukemia, Myeloid, Acute

Neoplasm Metastasis

Endometrial Neoplasms

Colonic Neoplasms

Mouth Neoplasms

Carcinoma, Non-Small-Cell Lung

Endometrial Neoplasms

Clinical Trials

Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer

Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

AMBASSADOR

Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy

High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma

DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

RB SFCE 09

Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast

Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma

REGAL

SABR-COMET 10

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

PORTEC-4a